Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-21

Clinical Trial Update: Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice

View source ↗

Summary

A completed clinical trial evaluated Remaxol® for gallstone disease complicated by obstructive jaundice. The study was sponsored by POLYSAN Scientific & Technol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remaxol

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Gallstone Disease, Obstructive Jaundice | Status: COMPLETED